Impact of vaccination and high-risk group awareness on the mpox epidemic in the United States, 2022-2023: a modelling study.

ABSTRACT:

Background

The unprecedented global outbreak of mpox in 2022 posed a public health challenge. In addition to the mpox vaccine campaign in the United States (US), community organisations and public health agencies initiated educational efforts to promote sexual risk reduction. This modelling study estimated the impact of the two-dose vaccination campaign and sexual behaviour changes coincident with high-risk group awareness on the mpox epidemic in the US.

Methods

We fitted a deterministic, risk-structured SEIARV model to the epidemic curve of reported mpox cases in the US between May 22, 2022 and December 22, 2022. We evaluated the putative effects of the two preventive responses in the US -- vaccination and sexual risk reduction -- at the population-level, by calculating the

SUBMITTER: Lin YC 

PROVIDER: S-EPMC10789643 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature